TheJournal.ie uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Click here to find out more »
Dublin: 13 °C Tuesday 21 May, 2013

Responding to Troika report, IPHA points to €1 billion savings since 2006

The organisation which represents drug manufacturers also said a greater use of generics is on the way.

Image: Martin Mejia/AP/Press Association Images

THE IRISH PHARMACEUTICAL Healthcare Association has responded to reports that the cost of drugs has come under particular scrutiny by Ireland’s bailout partners.

Although the representative body said it had not seen the leaked Troika documents, it pointed to a number of savings schemes that had been agreed over the past seven years.

In a statement, IPHA said, “While some of today’s media reports seem to point to OECD data from 2008, in the absence of the report, it remains unclear what the actual source of the figures are.

However, the Association acknowledges that prices were much higher in 2008, but there have been six significant price reductions undertaken since January 2009, the impact of which has not been analysed or reported in any of the recently published comparative studies.

“The research based industry has provided €400 million in savings in the recent supply agreement, which will result in a total saving to the State of €1 billion since 2006, together with access to the full range of innovative medicines for Irish patients.”

IPHA added that the calls for an increased use of generics will be met by forthcoming legislation, which will introduce reference pricing and generic substitution.

The European Commission document, seen by TheJournal.ie, suggests that the government puts in place a “claw-back mechanism” where a rebate is charged on pharmaceutical companies on a quarterly basis, as happens in other EU jurisdictions.

The Troika also outlined its belief that the health service should promote greater use of generic dugs and ensure prices of medications are more in line with other countries, highlighting the health service’s drugs bill is 34 per cent more per capita (individual person) terms than the EU average.

- additional reporting from Gavan Reilly

READ: Troika recommends cuts to specialist doctors’ salaries

Euroleaks: Troika wants less pay, more hours for public sector workers

More Euroleaks: Government to hire private companies to find work for long-term unemployed

Read next:

Comments (9 Comments)

  • Give them their dues..the troika are pulling back the covers on price fixing in this country..between this and the solicitors they might have just justified their existance here. Of course the politcal clsses should have done this years ago but that would require moral fibre and political courage.

    Reply
    • Many drug companies only care about their profit margins. In Greece the axe fell, in Ireland the butter-knife is barely falling.

      Reply
    • Only problem is Greece now has vast medicine shortages – hundreds of regular prescription medicines are not available in pharmacies or hospitals. There are several factors involved, reduction in prices has caused two of them.

      Reply
  • maura 11/01/13 #

    In to days Irish Times an article by Dan O’Brien says Irish drug costs increased by over 600% in past few years. More that any other European country

    Reply
  • It’s easy to to reduce prices when you are coming from a high base.

    That’s like a shop charging a fiver for an apple and patting themselves on the back when they reduce the price to three euro.

    Yeah, fantastic reduction but still profiteering.

    We pay approx 30% more for drugs than other countries with the same health outcomes as other countries.

    Reply
  • bought seretide inhaler for my s?n last year in spain 45 euro exact same one here 110 euro were being screwed here.

    Reply
  • BBB 12/01/13 #

    Perhaps it is also worth mentioning that drug reduction only apply to old drugs, whereas brand new ones are holding up steady.
    Also the big problem in Ireland is that generic medicines have a cost that is artificially high, so-called branded generic due to lack of competition and lack of ability for manufacturer to make big money on such a small market,. Again, this is the price of living on a small island.

    Reply
  • there are differences between some generic and brand name drugs in how the body absorbs them. course thats not important, or is it?

    Reply

Add New Comment